968 related articles for article (PubMed ID: 33562193)
21. COVID-19 and cardiovascular diseases.
Liu F; Liu F; Wang L
J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
[TBL] [Abstract][Full Text] [Related]
22. Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic.
Li Z; Xu X; Yang M; Feng J; Liu C; Yang C
Aging (Albany NY); 2020 Nov; 12(23):24453-24461. PubMed ID: 33197881
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
Nashiry A; Sarmin Sumi S; Islam S; Quinn JMW; Moni MA
Brief Bioinform; 2021 Mar; 22(2):1387-1401. PubMed ID: 33458761
[TBL] [Abstract][Full Text] [Related]
24. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
Speer G; Somogyi P
Endocr J; 2021 Feb; 68(2):129-136. PubMed ID: 33473054
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 and Cardiovascular Disease: From Bench to Bedside.
Chung MK; Zidar DA; Bristow MR; Cameron SJ; Chan T; Harding CV; Kwon DH; Singh T; Tilton JC; Tsai EJ; Tucker NR; Barnard J; Loscalzo J
Circ Res; 2021 Apr; 128(8):1214-1236. PubMed ID: 33856918
[TBL] [Abstract][Full Text] [Related]
26. Cardiology and COVID-19: do we have sufficient information?
Garg N; McClafferty B; Ramgobin D; Golamari R; Jain R; Jain R
Future Cardiol; 2021 Jul; 17(4):705-711. PubMed ID: 33124920
[TBL] [Abstract][Full Text] [Related]
27. ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis.
Poznyak AV; Bezsonov EE; Eid AH; Popkova TV; Nedosugova LV; Starodubova AV; Orekhov AN
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946649
[TBL] [Abstract][Full Text] [Related]
28. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
[TBL] [Abstract][Full Text] [Related]
29. Predictors of morbidity and mortality in COVID-19.
Gacche RN; Gacche RA; Chen J; Li H; Li G
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1684-1707. PubMed ID: 33629339
[TBL] [Abstract][Full Text] [Related]
30. The cardiovascular aspect of COVID-19.
Adu-Amankwaah J; Mprah R; Adekunle AO; Ndzie Noah ML; Adzika GK; Machuki JO; Sun H
Ann Med; 2021 Dec; 53(1):227-236. PubMed ID: 33345626
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular Outcomes in the Acute Phase of COVID-19.
Nakano H; Shiina K; Tomiyama H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920790
[TBL] [Abstract][Full Text] [Related]
32. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports.
Soumya RS; Unni TG; Raghu KG
Cardiovasc Drugs Ther; 2021 Jun; 35(3):411-425. PubMed ID: 32926272
[TBL] [Abstract][Full Text] [Related]
33. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
Mezoh G; Crowther NJ
Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
[TBL] [Abstract][Full Text] [Related]
34. Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics.
Choi HM; Moon SY; Yang HI; Kim KS
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572274
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 and cardiovascular disease: manifestations, pathophysiology, vaccination, and long-term implication.
Abdel Moneim A; Radwan MA; Yousef AI
Curr Med Res Opin; 2022 Jul; 38(7):1071-1079. PubMed ID: 35575011
[TBL] [Abstract][Full Text] [Related]
36. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
Maruhashi T; Higashi Y
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 and cardiovascular disease: a review of current knowledge.
Pal A; Ahirwar AK; Sakarde A; Asia P; Gopal N; Alam S; Kaim K; Ahirwar P; Sorte SR
Horm Mol Biol Clin Investig; 2021 Feb; 42(1):99-104. PubMed ID: 33544511
[TBL] [Abstract][Full Text] [Related]
38. The role of SARS-CoV-2 target ACE2 in cardiovascular diseases.
Zhu H; Zhang L; Ma Y; Zhai M; Xia L; Liu J; Yu S; Duan W
J Cell Mol Med; 2021 Feb; 25(3):1342-1349. PubMed ID: 33443816
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad.
Natarelli L; Virgili F; Weber C
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830125
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA).
Cenko E; Badimon L; Bugiardini R; Claeys MJ; De Luca G; de Wit C; Derumeaux G; Dorobantu M; Duncker DJ; Eringa EC; Gorog DA; Hassager C; Heinzel FR; Huber K; Manfrini O; Milicic D; Oikonomou E; Padro T; Trifunovic-Zamaklar D; Vasiljevic-Pokrajcic Z; Vavlukis M; Vilahur G; Tousoulis D
Cardiovasc Res; 2021 Dec; 117(14):2705-2729. PubMed ID: 34528075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]